Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care

We are excited to announce that Monarch Medical Technologies, the creator of EndoTool® Glucose Management System, has been acquired by Glooko, a global leader in diabetes management solutions.

For EndoTool customers, nothing changes in the care and support you receive. You will continue to work with the same Monarch team you know and trust.

What does change is the opportunity to bring our vision for patient-specific insulin dosing to an even broader stage.

Why this matters

Monarch has long been the leader in patient-specific inpatient insulin dosing, helping hospitals across the country deliver safe, more precise care.

By joining Glooko, we are extending this leadership beyond the hospital walls.

Together, we can connect the inpatient strengths of EndoTool with Glooko’s outpatient platform – supporting people with diabetes seamlessly across the continuum of care, from home to admission, through inpatient services, discharge, and back home again.

About Glooko

Glooko is a digital health company transforming care for people with diabetes and related chronic conditions.

Serving millions of users in more than 30 countries, Glooko’s platform seamlessly connects patients and providers with actionable data, remote monitoring, and decision support tools that improve health outcomes and support value-based care.

What’s next

• No disruption to EndoTool service or support.
• Expanded resources and global expertise as part of Glooko.
• Future innovation to create an integrated hospital-to-home solution for diabetes care.

At Monarch, our mission has always been to deliver precision, safety, and confidence in every insulin dose.

For current Monarch Medical Technology customers, if you have any questions, feel free to reach out to your Customer Success Manager.

Together with Glooko, we are building on that foundation to transform diabetes management across settings of care.

Media Contact

Julia Fuller
(858) 692-2001
[email protected]